Evaluating the Efficacy of Rituximab in Primary Membranous Nephropathy: An Observational Study from Southern India

被引：0
|
作者：
Saigal, Megha [1 ]
Guditi, Swarnalatha [1 ]
机构：
[1] Nizams Inst Med Sci, Hyderabad, Telangana, India
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1648
引用
收藏
页码：514 / 514
页数：1
相关论文
共 50 条
  • [11] Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
    Gao, Shuang
    Cui, Zhao
    Wang, Xin
    Zhang, Yi-miao
    Wang, Fang
    Cheng, Xu-yang
    Meng, Li-qiang
    Zhou, Fu-de
    Liu, Gang
    Zhao, Ming-hui
    FRONTIERS IN MEDICINE, 2021, 8
  • [12] Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
    Hu, Xiaofan
    Zhang, Muyin
    Xu, Jing
    Gao, Chenni
    Yu, Xialian
    Li, Xiao
    Ren, Hong
    Wang, Weiming
    Xie, Jingyuan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (12): : 1594 - 1602
  • [13] Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
    Liang, Hao
    Deng, Zhenling
    Niu, Shu
    Kong, Weijie
    Liu, Yang
    Wang, Song
    Li, Haiyan
    Wang, Yue
    Zheng, Danxia
    Liu, Dongyang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [14] A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy
    Wang, Yi
    Ma, Xiaoyan
    Yang, Xinyu
    Bai, Shoujun
    Zang, Xiujuan
    Liao, Lin
    Wang, Yakun
    Lv, Zexin
    Zhang, Ting
    Zhuang, Shougang
    Liu, Na
    RENAL FAILURE, 2024, 46 (02)
  • [15] Optimization of rituximab therapy in primary membranous nephropathy with artificial intelligence
    Destere, A.
    Teyssiere, M.
    Merino, D.
    Cremoni, M.
    Benito, S.
    Gerard, A.
    Drici, M. D.
    Seitz-Polski, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 74 - 75
  • [16] Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
    Naik, Sachin
    Pal, Deeksha
    Shukla, Shubham
    Kumar, Vinod
    Kumar, Ashwini
    Jha, Vivekanand
    Minz, Ranjana
    Sethi, Jasmine
    Bharati, Joyita
    Divyaveer, Smita
    Kumar, Vivek
    Rathi, Manish
    Kohli, Harbir Singh
    Ramachandran, Raja
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (08): : 1660 - 1664
  • [17] EFFECT OF RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY MEMBRANOUS NEPHROPATHY
    Akyildiz, Arif
    Uludag, Omer
    Mirioglu, Safak
    Ucar, Ali Riza
    Demir, Erol
    Caliskan, Yasar Kerem
    Ozluk, Yasemin
    Turkmen, Aydin
    Sever, Mehmet Sukru
    Yazici, Halil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 657 - 657
  • [18] Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
    Xu, Mingyue
    Wang, Yifeng
    Wu, Meihe
    Chen, Ruiying
    Zhao, Wenqian
    Li, Mingxin
    Hao, Chuan-Ming
    Xie, Qionghong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
  • [19] Rituximab, Use and B Cell Depletion in Patients with Membranous Nephropathy- A Retrospective, Observational Study
    Gaggar, Payal
    Madipally, Ravitej
    Raju, Sree B.
    INDIAN JOURNAL OF NEPHROLOGY, 2023, 33 (05) : 356 - 361
  • [20] Efficacy of tacrolimus monotherapy in primary membranous nephropathy
    Zhang, Ya-pu
    Ran, Lei
    Guo, Li
    Gou, Yan-Li
    Guo, Shan-shan
    Xu, Yang
    Hua, Xin
    Chen, Hang
    OPEN MEDICINE, 2024, 19 (01):
12345